Ciongoli Gregory Austin
SEC Form 4 history across 2 companies, 5 transactions and 2 filings.
Available history · Aug 25, 2026 – Sep 23, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
GOSSGossamer Bio, Inc. | Ciongoli Gregory AustinDIR | A · grantDerivative securitySEC filing ↗ | $0View disclosure → | |
RGNXREGENXBIO Inc. | Ciongoli Gregory AustinDIR | A · grantDerivative securitySEC filing ↗ | $0View disclosure → | |
RGNXREGENXBIO Inc. | Ciongoli Gregory AustinDIR | P · buySEC filing ↗ | $499kView disclosure → | |
RGNXREGENXBIO Inc. | Ciongoli Gregory AustinDIR | P · buySEC filing ↗ | $449kView disclosure → | |
RGNXREGENXBIO Inc. | Ciongoli Gregory AustinDIR | A · grantSEC filing ↗ | $0View disclosure → |
Latest Form 4 facts
Quick context from source filings
buy at REGENXBIO Inc. on Aug 27, 2026 valued at $499,676.
Review SEC filingNo open-market insider sale is available.
Monthly open-market activity
Last 2 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| Aug 2026 | 2 | 0 | $949,381.45 | $0.00 | $949,381.45 |
| Sep 2026 | 0 | 0 | $0.00 | $0.00 | $0.00 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
No purchases currently have the price observations needed for a 90-day return. This may reflect incomplete price coverage or purchases that have not reached the return window.
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
3 observations · Aug 25, 2026 – Aug 27, 2026. Window ends at the latest available report, not today.
View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Aug 25, 2026 | 15,432 | Aug 27, 2026 | View transaction |
| Aug 26, 2026 | 64,628 | Aug 27, 2026 | View transaction |
| Aug 27, 2026 | 118,035 | Aug 27, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Ciongoli Gregory Austin Insider Activity FAQ
SEC Form 4 context
Who is Ciongoli Gregory Austin?
Ciongoli Gregory Austin is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002023732.
Which companies has Ciongoli Gregory Austin reported transactions for?
Gossamer Bio, Inc., REGENXBIO Inc., Zymeworks Inc.
When was Ciongoli Gregory Austin's latest insider buy?
buy at REGENXBIO Inc. on Aug 27, 2026 valued at $499,676.
When was Ciongoli Gregory Austin's latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.